Curemark Medi Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 10-07-2024
- Paid Up Capital ₹ 0.10 M
as on 10-07-2024
- Company Age 6 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.99 M
as on 10-07-2024
- Revenue 7.73%
(FY 2023)
- Profit -125.44%
(FY 2023)
- Ebitda -15.67%
(FY 2023)
- Net Worth -198.57%
(FY 2023)
- Total Assets 3.28%
(FY 2023)
About Curemark Medi Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.99 M.
Sukesha Manjupoojari, Pallavi Hotagigouder, Umesh Hotagigoudr, and One other member serve as directors at the Company.
- CIN/LLPIN
U74999KA2018PTC111014
- Company No.
111014
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Mar 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Dharwad, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Curemark Medi Sciences Private Limited offer?
Curemark Medi Sciences Private Limited offers a wide range of products and services, including Child and Baby Care Products, Baby Care Products.
Who are the key members and board of directors at Curemark Medi Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Umesh Hotagigoudr  | Managing Director | 12-Mar-2018 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sukesha Manjupoojari | Director | 12-Mar-2018 | Current |
| Pallavi Hotagigouder | Director | 12-Mar-2018 | Current |
| Pradeep Puttaraju | Director | 01-Oct-2020 | Current |
Financial Performance and Corporate Structure Insights of Curemark Medi Sciences.
Curemark Medi Sciences Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 7.73% increase. The company also saw a substantial fall in profitability, with a 125.44% decrease in profit. The company's net worth observed a substantial decline by a decrease of 198.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Curemark Medi Sciences?
Unlock access to Curemark Medi Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 11 Aug 2020 | ₹0.99 M | Open |
How Many Employees Work at Curemark Medi Sciences?
Unlock and access historical data on people associated with Curemark Medi Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Curemark Medi Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Curemark Medi Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
